OCUL
Ocular Therapeutix Inc
Price:  
6.17 
USD
Volume:  
1,186,465.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

OCUL EV/EBITDA

-218.2%
Upside

As of 2024-05-20, the EV/EBITDA ratio of Ocular Therapeutix Inc (OCUL) is -6.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OCUL's latest enterprise value is 538.25 mil USD. OCUL's TTM EBITDA according to its financial statements is -88.02 mil USD. Dividing these 2 quantities gives us the above OCUL EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.4x - 18.1x 14.5x
Forward P/E multiples 18.9x - 21.1x 20.6x
Fair Price (8.04) - (7.62) (7.29)
Upside -230.3% - -223.5% -218.2%
6.17 USD
Stock Price
(7.29) USD
Fair Price

OCUL EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-17 -6.11
2024-05-16 -6.29
2024-05-15 -6.33
2024-05-14 -5.90
2024-05-13 -5.18
2024-05-10 -5.22
2024-05-09 -5.53
2024-05-08 -5.38
2024-05-07 -5.69
2024-05-06 -5.46
2024-05-03 -6.11
2024-05-02 -5.59
2024-05-01 -4.09
2024-04-30 -3.60
2024-04-29 -3.71
2024-04-26 -3.61
2024-04-25 -2.65
2024-04-24 -3.43
2024-04-23 -4.06
2024-04-22 -4.19
2024-04-19 -4.44
2024-04-18 -5.57
2024-04-17 -8.59
2024-04-16 -8.96
2024-04-15 -8.98
2024-04-12 -9.31
2024-04-11 -9.82
2024-04-10 -9.17
2024-04-09 -9.63
2024-04-08 -9.31
2024-04-05 -10.11
2024-04-04 -10.16
2024-04-03 -10.12
2024-04-02 -10.18
2024-04-01 -10.54
2024-03-28 -11.27
2024-03-27 -11.63
2024-03-26 -11.44
2024-03-25 -11.81
2024-03-22 -11.95
2024-03-21 -13.11
2024-03-20 -12.67
2024-03-19 -12.32
2024-03-18 -11.86
2024-03-15 -11.90
2024-03-14 -11.55
2024-03-13 -12.13
2024-03-12 -11.60
2024-03-11 -12.37
2024-03-08 -12.81